alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

[ENDO LOGO]
100 Painters Dr.
Chadds Ford, PA 19317
610-558-9800
www.endo.com

                                                                 Exhibit 10.43.2

                                               March 2, 2004

BY FACSIMILE & OVERNIGHT MAIL
Michael Ashton
SkyePharma, Inc.
105 Piccadilly
London W1J 7NJ
England

Dear Michael:

         Reference is hereby made to that certain Development and Marketing
Strategic Alliance Agreement, dated as of December 31, 2002 (as amended, the
"Agreement"), among Endo Pharmaceuticals Inc. ("Endo"), SkyePharma, Inc. and
SkyePharma Canada Inc. (collectively, "Skye"). Defined terms used but not
defined herein shall have the meanings set forth in the Agreement.

         The purpose of this letter is to amend and restate the fifth milestone
on the chart set forth in Section 4.2 of the Agreement which milestone relates
to the FDA's written approval and acceptance of the protocol of the first of the
Phase III clinical trials for Propofol IDD-D in the United States (the "Propofol
Protocol Milestone"). Now for good and valuable consideration, the sufficiency
and receipt of which is hereby acknowledged, the Parties agree that the Propofol
Protocol Milestone is amended and restated as follows:

<TABLE>
<S>                                                                    <C>                       <C>
With respect to Propofol IDD-D, upon the earlier of (a) the JEC's      Two (2) days following    $5,000,000
approval of the FDA protocol submission package, which shall           occurrence of Milestone
follow Endo's receipt of both the FDA end-of-Phase II (EOPII)          Event
meeting minutes and the timeline for the Phase III clinical plan,
or (b) 30 days following Endo's receipt of the FDA EOPII meeting
minutes and the timeline for the Phase III clinical plan.
</TABLE>

<PAGE>

Michael Ashton
SkyePharma, Inc.
March 2, 2004
Page Two

         Other than as set forth in this letter agreement, all other terms and
conditions of the Agreement remain the same and in full force and effect.

         If Skye is in agreement with the above, please have a duly authorized,
appropriate officer countersign this letter below.

                                                              Very truly yours,

                                                              /S/ CAROL A. AMMON

                                                              Carol A. Ammon

ACCEPTED AND AGREED THIS 2nd DAY OF MARCH 2004:

SKYEPHARMA, INC.

By /s/ MICHAEL ASHTON
   ----------------------
   Name: Michael Ashton
   Title: CEO

SKYEPHARMA CANADA INC.

By /s/ MICHAEL ASHTON
   -------------------------
   Name: Michael Ashton
   Title: Director
[Federal Register Volume 60, Number 105 (Thursday, June 1, 1995)]
[Notices]
[Page 28616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13291]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration on Aging


White House Conference on Aging

agency: White House Conference on Aging, AoA, HHS.

action: Notice of meeting.

-----------------------------------------------------------------------

summary: Notice is hereby given, pursuant to Title II of the Older 
Americans Act Amendments of 1987, Pub. L. 100-175 as amended by Pub. L. 
102-375, and Pub. L. 103-171, that the 1995 White House Conference on 
Aging Advisory Committee will hold a meeting on Wednesday, June 14, 
1995, in Washington, DC. The general meeting will begin at 10:00 a.m. 
and end at approximately 12:00 noon. More specific information on the 
location for the meeting can be obtained by calling the telephone 
number given below.
    The general meeting of the Committee shall be open to the public. 
The proposed agenda includes preparation of the proposed report of the 
Conference which is to be transmitted to the chief executive officers 
of the States by August 3, 1995.
    Records shall be kept of all Committee proceedings and shall be 
available for public inspection at 501 School Street SW., 8th Floor, 
Washington, DC 20024.

for further information contact: White House Conference on Aging, 501 
School Street SW., 8th Floor, Washington, DC 20024; telephone (202) 
245-7116.

    Dated: May 25, 1995.
Fernando M. Torres-Gil,
Assistant Secretary for Aging.
[FR Doc. 95-13291 Filed 5-31-95; 8:45 am]
BILLING CODE 4130-02-M
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Vegetable Crops Research: Madison, WI
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    ScientistsSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Midwest Area Madison, Wisconsin Vegetable Crops Research Docs







Aboutusheadline bar Click Here for individual research programs in the Vegetable Crops Research Unit The Vegetable Crops Research Unit of the Agricultural Research Service branch of the United States Department of Agriculture is located in Madison, Wisconsin, and is associated with the Department of Horticulture at the University of Wisconsin-Madison **Mission:**The mission of the research unit is to investigate the genetics, cytogenetics, taxonomy, gene flow, disease resistance, insect interactions, molecular biology and breeding strategies of vegetable and fruit crops. This includes the investigation of chromosome behavior, phylogeny, pest resistance and suppression, intra-and interspecific crossing, nutritional quality, flavor, storage quality, and effects of environmental stress and insects on Solanum species, carrot, cucumber, onion, garlic, and cranberries. This also includes the use of exotic germplasm, germplasm enhancement, and development of production technologies where needed. Philipp W SimonResearch Leader(608) 262-1248Department of Horticulture, University of Wisconsin-Madison1575 Linden DriveMadison WI 53706


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
#### CHILCOTT, Appellant, v. BROADWAY BREWING & MALTING CO. et al., Respondents.

(Supreme Court, Appellate Division, Fourth Department.

March 6, 1912.)

Action by Alfred W. Chilcott against the Broadway Brewing & Malting Company and another. No opinion. Judgment affirmed, with costs.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1760 Referred in Senate (RFS)]

  1st Session
                                H. R. 1760

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 17, 2005

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
at 215 Martin Luther King, Jr. Boulevard in Madison, Wisconsin, as the 
          ``Robert M. La Follette, Sr. Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The facility of the United States Postal Service located at 215 
Martin Luther King, Jr. Boulevard in Madison, Wisconsin, shall be known 
and designated as the ``Robert M. La Follette, Sr. Post Office 
Building''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the facility referred to in section 1 
shall be deemed to be a reference to the ``Robert M. La Follette, Sr. 
Post Office Building''.

            Passed the House of Representatives May 16, 2005.

            Attest:

                                                 JEFF TRANDAHL,

                                                                 Clerk.
```
USDC IN/ND case 3:15-cv-00463-JD   document 16   filed 10/22/15   page 1 of 3

USDC IN/ND case 3:15-cv-00463-JD   document 16   filed 10/22/15   page 2 of 3

10/22/2015 S/Christopher A Nuechterlein

USDC IN/ND case 3:15-cv-00463-JD   document 16   filed 10/22/15   page 3 of 3
EXHIBIT 31.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002



I, Antonio E. Turgeon certify that:



1. I have reviewed this annual report of TechnoConcepts, Inc. (formerly

Technology Consulting Partners, Inc.);



2. Based on my knowledge, this report does not contain any untrue statement of a

material fact or omit to state a material fact necessary to make the statements

made, in light of the circumstances under which such statements were made, not

misleading with respect to the period covered by this report;



3. Based on my knowledge, the financial statements, and other financial

information included in this report, fairly present in all material respects the

financial condition, results of operations and cash flows of the small business

issuer as of, and for, the periods presented in this report;



4. I am responsible for establishing and maintaining disclosure controls and

procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the

small business issuer and have:



(a) Designed such disclosure controls and procedures, or caused such disclosure

controls and procedures to be designed under my supervision, to ensure that

material information relating to the small business issuer, including its

consolidated subsidiaries, is made known to me by others within those entities,

particularly during the period in which this report is being prepared;



(b) Evaluated the effectiveness of the small business issuer's disclosure

controls and procedures and presented in this report my conclusions about the

effectiveness of the disclosure controls and procedures, as of the end of the

period covered by this report based on such evaluation; and



(c) Disclosed in this report any change in the small business issuer's internal

control over financial reporting that occurred during the small business

issuer's most recent fiscal quarter (the small business issuer's fourth fiscal

quarter in the case of an annual report) that has materially affected, or is

reasonably likely to materially affect, the small business issuer's internal

control over financial reporting; and



5. I have disclosed, based on my most recent evaluation of internal control over

financial reporting, to the small business issuer's auditors and the audit

committee of the small business issuer's board of directors (or persons

performing the equivalent functions):



(a) All significant deficiencies and material weaknesses in the design or

operation of internal control over financial reporting which are reasonably

likely to adversely affect the small business issuer's ability to record,

process, summarize and report financial information; and



(b) Any fraud, whether or not material, that involves management or other

employees who have a significant role in the small business issuer's internal

control over financial reporting.



Date: January 13, 2005



/s/ Antonio E. Turgeon

----------------------

Antonio E. Turgeon, President,

Chief Executive Officer
# L_2008260EN.01006001.xml

| 30.9.2008 | EN | Official Journal of the European Union | L 260/60 |
| --- | --- | --- | --- |

30.9.2008

EN

Official Journal of the European Union

L 260/60

---

COUNCIL COMMON POSITION 2008/761/CFSP

of 29 September 2008

extending Common Position 2004/694/CFSP on further measures in support of the effective implementation of the mandate of the International Criminal Tribunal for the former Yugoslavia (ICTY)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 15 thereof,

Whereas:

| (1) | On 11 October 2004, the Council adopted Common Position 2004/694/CFSP (1), with the aim of freezing all funds and economic resources belonging to all persons who have been publicly indicted by the ICTY for war crimes but who are not in the custody of the ICTY. |
| --- | --- |

(1)

On 11 October 2004, the Council adopted Common Position 2004/694/CFSP (1), with the aim of freezing all funds and economic resources belonging to all persons who have been publicly indicted by the ICTY for war crimes but who are not in the custody of the ICTY.

| (2) | Common Position 2004/694/CFSP applies until 10 October 2008. |
| --- | --- |

(2)

Common Position 2004/694/CFSP applies until 10 October 2008.

| (3) | The Council considers it necessary to renew Common Position 2004/694/CFSP for a further period of 12 months. |
| --- | --- |

(3)

The Council considers it necessary to renew Common Position 2004/694/CFSP for a further period of 12 months.

| (4) | The Community implementing measures are set out in Regulation (EC) No 1763/2004 of 11 October 2004 imposing certain restrictive measures in support of effective implementation of the mandate of the International Criminal Tribunal for the former Yugoslavia (ICTY) (2), |
| --- | --- |

(4)

The Community implementing measures are set out in Regulation (EC) No 1763/2004 of 11 October 2004 imposing certain restrictive measures in support of effective implementation of the mandate of the International Criminal Tribunal for the former Yugoslavia (ICTY) (2),

HAS ADOPTED THIS COMMON POSITION:

Article 1

Common Position 2004/694/CFSP is hereby extended until 10 October 2009.

Article 2

This Common Position shall take effect on the date of its adoption.

Article 3

This Common Position shall be published in the Official Journal of the European Union.

Done at Brussels, 29 September 2008.

For the Council

The President

M. BARNIER

---

(1)  
  OJ L 315, 14.10.2004, p. 52.

1

(2)  
  OJ L 315, 14.10.2004, p. 14.

2

---
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1843 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 1843

                To suspend temporarily the duty on MCPA.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 26, 2005

  Mr. Graves introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
                To suspend temporarily the duty on MCPA.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MCPA.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.06.18      2-ethylhexyl (4-    Free         No change        No change        On or before 12/  ''.
                         chloro-2-                                                          31/2008
                         methylphenoxy)ace
                         tate (CAS No.
                         29450-45-1)
                         (provided for in
                         subheading
                         2918.90.25)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of enactment of this Act.
                                 <all>
```
OBAYDULLAH, petitioner, v. Barack H. OBAMA, President of the United States, et al.

No. 12-8932.

Supreme Court of the United States

June 24, 2013.

Motion of respondents for leave to file brief in opposition under seal granted. Motion of petitioner for leave to file reply brief under seal granted. Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.
Exhibit 32.4
  CERTIFICATION
PURSUANT TO
 18
U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
  In
connection with the Annual Report of Procera Networks, Inc. (the “Company”) on
Form 10-K/A for the year ended December 31, 2007, as filed with the Securities
and Exchange Commission (the “Report”), I, Paul Eovino, interim Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
  (1)         The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
  (2)         The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
   March
      10, 2009
                        
                        By:
                        /s/    Paul EovinoPaul Eovinointerim
      Chief Financial
Officer
 
  This
certification accompanies this Report on Form 10-K/A pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
such Act, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended. A signed original of this written
statement required by Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.
# L_2008105EN.01001001.xml

| 15.4.2008 | EN | Official Journal of the European Union | L 105/10 |
| --- | --- | --- | --- |

15.4.2008

EN

Official Journal of the European Union

L 105/10

---

COUNCIL JOINT ACTION 2008/304/CFSP

of 14 April 2008

amending and extending Joint Action 2005/190/CFSP on the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 14 thereof,

Whereas:

| (1) | On 7 March 2005, the Council adopted Joint Action 2005/190/CFSP on the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX (1). |
| --- | --- |

(1)

On 7 March 2005, the Council adopted Joint Action 2005/190/CFSP on the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX (1).

| (2) | On 22 November 2007, the Council adopted Joint Action 2007/760/CFSP (2) amending and extending Joint Action 2005/190/CFSP until 30 April 2008. |
| --- | --- |

(2)

On 22 November 2007, the Council adopted Joint Action 2007/760/CFSP (2) amending and extending Joint Action 2005/190/CFSP until 30 April 2008.

| (3) | Joint Action 2005/190/CFSP should be further extended until 30 June 2008. |
| --- | --- |

(3)

Joint Action 2005/190/CFSP should be further extended until 30 June 2008.

| (4) | The financial reference amount of EUR 10 million provided for in Council Joint Action 2005/190/CFSP was supplemented by EUR 11,2 million in Council Joint Action 2006/708/CFSP (3), which should also cover the expenditure to be incurred during the remaining period of the Mission, |
| --- | --- |

(4)

The financial reference amount of EUR 10 million provided for in Council Joint Action 2005/190/CFSP was supplemented by EUR 11,2 million in Council Joint Action 2006/708/CFSP (3), which should also cover the expenditure to be incurred during the remaining period of the Mission,

HAS ADOPTED THIS JOINT ACTION:

Article 1

Joint Action 2005/190/CFSP is hereby amended as follows:

| 1. | Article 11(1) shall be replaced by the following:

  ‘1.   The financial reference amount intended to cover the expenditure related to the mission for the period 7 March 2005 to 30 June 2008 shall be EUR 21,2 million.’; |
| --- | --- |

1.

Article 11(1) shall be replaced by the following:

‘1.   The financial reference amount intended to cover the expenditure related to the mission for the period 7 March 2005 to 30 June 2008 shall be EUR 21,2 million.’;

| 2. | the second subparagraph of Article 14 shall be replaced by the following:
  ‘It shall expire on 30 June 2008.’ |
| --- | --- |

2.

the second subparagraph of Article 14 shall be replaced by the following:

‘It shall expire on 30 June 2008.’

Article 2

This Joint Action shall enter into force on the date of its adoption.

Article 3

This Joint Action shall be published in the Official Journal of the European Union.

Done at Luxembourg, 14 April 2008.

For the Council

The President

I. JARC

---

(1)  
  OJ L 62, 9.3.2005, p. 37.

1

(2)  
  OJ L 305, 23.11.2007, p. 58.

2

(3)  
  OJ L 291, 21.10.2006, p. 43.

3

---
Exhibit
32.1
  CERTIFICATION
PURSUANT TO
 18
U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
  In
connection with the Annual Report of Procera Networks, Inc. (the “Company”) on
Form 10-K for the year ended December 31, 2008, as filed with the Securities and
Exchange Commission (the “Report”), I, James F. Brear, President and Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
  (1)           The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
  (2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
  March
      16, 2009
                    By:
                    /s/    James
      F. BrearJames
      F. Brear
                      President
      and Chief Executive
Officer
  This
certification accompanies this Report on Form 10-K pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
such Act, be deemed filed by the Company for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended. A signed original of this written
statement required by Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.